Berlin, Germany

Friedmund Neumann


Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 107(Granted Patents)


Company Filing History:


Years Active: 1976-2004

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Friedmund Neumann: Innovator in Androgen Deficiency Treatment

Introduction

Friedmund Neumann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of androgen deficiency in men. With a total of eight patents to his name, Neumann's work has had a considerable impact on medical science.

Latest Patents

One of Neumann's latest patents involves the combination of dehydroepiandrosterone (DHEA) and aromatase inhibitors. This innovative combination is used to produce a medicament aimed at treating both relative and absolute androgen deficiency in men. The invention emphasizes the use of selective aromatase inhibitors such as atamestan, formestan, pentrozol, aramidex, fadrozol, CGS 20267, and vorozol, which are preferred for creating the medicament.

Career Highlights

Friedmund Neumann has had a distinguished career, working with Schering Aktiengesellschaft, a prominent pharmaceutical company. His expertise in the field has led to advancements in treatments that address hormonal deficiencies, showcasing his commitment to improving men's health.

Collaborations

Neumann has collaborated with notable colleagues, including Ursula Lachnit-Fixson and Albert Radlmaier. These partnerships have contributed to the development of innovative solutions in the medical field.

Conclusion

Friedmund Neumann's contributions to the treatment of androgen deficiency through his innovative patents highlight his role as a significant figure in medical research. His work continues to influence the development of effective treatments for men facing hormonal challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…